HIV-Selectest enzyme immunoassay and rapid test: Ability to detect seroconversion following HIV-1 infection

Journal of Clinical Microbiology

Volumn 48, Issue 1, 2010, Pages 281-285

  Khurana, Surender ^a   Norris, Philip J ^b,c   Busch, Michael P ^b,c   Haynes, Barton F ^d   Park, Susan ^a   Sasono, Pretty ^a   Mlisana, Koleka ^e   Salim, Abdool Karim ^e   Hecht, Frederick M ^c   Mulenga, Joseph ^f,g   Chomba, Elwyn ^g   Hunter, Eric ^h   Allen, Susan ⁱ   Nemo, George ^j   Rodriguez Chavez, Isaac R ^k   Margolick, Joseph B ^l   Golding, Hana ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

^f Zambia Emory HIV Research Project   (Zambia)

^g Zambia Blood Transfusion Service   (Zambia)

^h EMORY UNIVERSITY   (United States)

ⁱ EMORY UNIVERSITY   (United States)

^j NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^k NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^l JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOASSAY; MALE; NONHUMAN; NOTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROCONVERSION; VIRUS DETECTION; VIRUS LOAD;

ANTIBODIES, VIRAL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; SENSITIVITY AND SPECIFICITY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 73949156379     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01573-09     Document Type: Note

References (11)

1. Fiebig, E. W., D. J. Wright, B. D. Rawal, P. E. Garrett, R. T. Schumacher, L. Peddada, C. Heldebrant, R. Smith, A. Conrad, S. H. Kleinman, and M. P. Busch. 2003. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871-1879.
2. Gray, E. S., P. L. Moore, I. A. Choge, J. M. Decker, F. Bibollet-Ruche, H. Li, N. Leseka, F. Treurnicht, K. Mlisana, G. M. Shaw, S. S. Karim, C. Williamson, and L. Morris. 2007. Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J. Virol. 81:6187-6196.
3. Haaland, R. E., P. A. Hawkins, J. Salazar-Gonzalez, A. Johnson, A. Tichacek, E. Karita, O. Manigart, J. Mulenga, B. F. Keele, G. M. Shaw, B. H. Hahn, S. A. Allen, C. A. Derdeyn, and E. Hunter. 2009. Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog. 5:e1000274.
4. Khurana, S., J. Needham, B. Mathieson, I. R. Rodriguez-Chavez, A. T. Catanzaro, R. T. Bailer, J. Kim, V. Polonis, D. A. Cooper, J. Guerin, M. L. Peterson, M. Gurwith, N. Nguyen, B. S. Graham, and H. Golding. 2006. Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies. J. Virol. 80:2092-2099.
5. Khurana, S., J. Needham, S. Park, B. Mathieson, M. P. Busch, G. Nemo, P. Nyambi, S. Zolla-Pazner, S. Laal, J. Mulenga, E. Chomba, E. Hunter, S. Allen, J. McIntyre, I. Hewlett, S. Lee, S. Tang, E. Cowan, C. Beyrer, M. Altfeld, X. G. Yu, A. Tounkara, O. Koita, A. Kamali, N. Nguyen, B. S. Graham, D. Todd, P. Mugenyi, O. Anzala, E. Sanders, N. Ketter, P. Fast, and H. Golding. 2006. Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 43:304-312.
6. McKenna, S. L., G. K. Muyinda, D. Roth, M. Mwali, N. Ng'andu, A. Myrick, C. Luo, F. H. Priddy, V. M. Hall, A. A. von Lieven, J. R. Sabatino, K. Mark, and S. A. Allen. 1997. Rapid HIV testing and counseling for voluntary testing centers in Africa. AIDS 11(Suppl. 1):S103-S110.
7. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
8. Napravnik, S., C. Poole, J. C. Thomas, and J. J. Eron, Jr. 2002. Gender difference in HIV RNA levels: a meta-analysis of published studies. J. Acquir. Immune Defic. Syndr. 31:11-19.
9. Tomaras, G. D., N. L. Yates, P. Liu, L. Qin, G. G. Fouda, L. L. Chavez, A. C. Decamp, R. J. Parks, V. C. Ashley, J. T. Lucas, M. Cohen, J. Eron, C. B. Hicks, H. X. Liao, S. G. Self, G. Landucci, D. N. Forthal, K. J. Weinhold, B. F. Keele, B. H. Hahn, M. L. Greenberg, L. Morris, S. S. Karim, W. A. Blattner, D. C. Montefiori, G. M. Shaw, A. S. Perelson, and B. F. Haynes. 2008. Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82:12449-12463.
10. Touloumi, G., N. Pantazis, A. G. Babiker, S. A. Walker, O. Katsarou, A. Karafoulidou, A. Hatzakis, and K. Porter. 2004. Differences in HIV RNA levels before the initiation of antiretroviral therapy among 1864 individuals with known HIV-1 seroconversion dates. AIDS 18:1697-1705.
11. Wilson, T. E., Y. Barron, M. Cohen, J. Richardson, R. Greenblatt, H. S. Sacks, and M. Young. 2002. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin. Infect. Dis. 34:529-534.